All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

65

Reset

65 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • KVA12123Phase 21 trial

    Kineta Inc. · Cancer, Solid Tumor, Melanoma

  • lonigutamabPhase 21 trial

    ACELYRIN Inc. · Thyroid Eye Disease

  • MAR002Phase 21 trial

    Marea Therapeutics · Acromegaly

  • NBIP-01435Phase 21 trial

    Neurocrine Biosciences · Congenital Adrenal Hyperplasia

  • NEO-201Phase 21 trial

    Precision Biologics, Inc · Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Cervical Cancer

  • NLS-133Phase 21 trial

    Next Life Sciences · Male Contraception, Semen Volume, Sperm Motility

  • NOE-115Phase 21 trial

    Noema Pharma AG · Menopause Syndrome, Menopause, Hot Flashes

  • NTB003Phase 21 trial

    Nanjing Chia-tai Tianqing Pharmaceutical · Thyroid Eye Disease

  • OG-6219Phase 21 trial

    Organon and Co · Endometriosis

  • SAL056Phase 21 trial

    Shenzhen Salubris Pharmaceuticals Co., Ltd. · Postmenopausal Women With Osteoporosis

  • SNS-101anti-VISTAPhase 21 trial

    Sensei Biotherapeutics, Inc. · Solid Tumor, Adult, Advanced Solid Tumor, Head and Neck Cancer

  • VipoglanstatPhase 21 trial

    Gesynta Pharma AB · Endometriosis

  • VLS-1488Phase 21 trial

    Volastra Therapeutics, Inc. · Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer

  • XP-102Phase 21 trial

    Xynomic Pharmaceuticals, Inc. · Cancer, BRAF V600 Mutation, Melanoma

  • YCT-529Phase 21 trial

    YourChoice Therapeutics, Inc. · Male Contraception

NewerPage 2 of 2

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.